,,iv  #aaf? ,,congress  #a/ ,session    
,h4 ,,res4 #cca  ,,9 ,,! ,,h\se ,,(     
,,repres5tatives  ,april #cj1 #bjai,mr4 
,johnson ( ,georgia 7= himself1 ,ms4    
,m5g1 ,mr4 ,fitzpatrick1 ,ms4 ,lee (    
,cali=nia1 ,mr4 ,lewis1 ,ms4 ,norton1   
,mr4 ,grijalva1 ,mrs4 ,watson ,coleman1 
& ,ms4 ,judy ,*u ( ,cali=nia7 submitt$ !
 foll[+ resolution2 :i* 0 ref]r$ to !   
,committee on ,en]gy & ,comm]ce         
,,resolution  ,express+ support = !     
designation ( ,april #cj z ,national    
,adult ,hepatitis ,b ,vacc9ation        
,aw>5ess ,day4  ,:]eas up to #b4b       
million individuals 9 ! ,unit$ ,/ates   
are *ronically infect$ ) hepatitis ,b1 &
 up to two-?irds ( individuals ) *ronic 
hepatitis ,b are unaw>e ( _! infection  
/atus2 ,:]eas hepatitis ,b is a viral   
infection ( ! liv] transmitt$ via       
infect$ blood & o!r body fluids1 includ+
 "m-to-*ild transmission & transmission 
?r\gh injection drug use2 ,:]eas        
individuals ) *ronic diseases su* z     
diabetes1 ,,hiv1 hepatitis ,c1 & *ronic 

liv] disease1 & individuals on          
hemodialysis are at an increas$ risk =  
hepatitis ,b co-infection2 ,:]eas !re is
 no cure = hepatitis ,b & individuals ) 
*ronic hepatitis ,b require lifelong    
m$ical c>e2 ,:]eas *ronic hepatitis ,b  
repres5ts "o ( ! mo/ common causes (    
liv] canc]2 ,:]eas #a 9 e #d individuals
 ) unmanag$ *ronic hepatitis ,b w       
develop liv] canc]1 cirrhosis1 or liv]  
failure1 ) liv] canc] only hav+ an #ah  
p]c5t #e-ye> survival rate 9 ! ,unit$   
,/ates2 ,:]eas safe & highly effective  
vacc9es to protect aga9/ hepatitis ,b   
are curr5tly available & infants &      
*ildr5 h be5 r\t9ely vacc9at$ aga9/     
hepatitis ,b s9ce ! #aiijs 9 accordance 
) univ]sal *ildhood hepatitis ,b        
vacc9ation recomm5dations 9 ! ,unit$    
,/ates2 ,:]eas ! hepatitis ,b vacc9e1   
:i* is #ie p]c5t effective & 0 ! fir/   
anticanc] vacc9e to be develop$1 is     
project$ to prev5t #caj million cases ( 
hepatitis ,b worldwide f #aiij to #bjbj2
 ,:]eas only #be p]c5t ( adults are     

vacc9at$ aga9/ hepatitis ,b 9 ! ,unit$  
,/ates2 ,:]eas ! numb] ( report$ acute  
hepatitis ,b cases increas$ by #bj p]c5t
 nationwide 9 #bjae1 & !re h be5        
significant regional increases 9 acute  
hepatitis ,b cases 9 ! ,unit$ ,/ates z a
 result ( ! opioid epidemic1 ) ,ma9e    
report+ a #gbi-p]c5t increase 9 acute   
hepatitis ,b infections f #bjae to      
#bjag1 ,k5tucky1 ,we/ ,virg9ia1 &       
,t5nessee report+ a #aad-p]c5t increase 
f #bjji to #bjac1 s\!a/]n ,massa*usetts 
report+ a #gh-p]c5t increase 9 #bjag1 & 
,nor? ,c>ol9a report+ a #fb-p]c5t       
increase f #bjab to #bjaf2 ,:]eas1      
accord+ to ! ,c5t]s = ,disease ,control 
& ,prev5tion1 hepatitis ,b is #ej to    
#ajj times m infecti\s ?an ,,hiv & #e to
 #aj times m infecti\s ?an hepatitis ,c2
 & ,:]eas !re are significant           
opportunities to prev5t new hepatitis ,b
 infections & subsequ5tly r$uce !       
incid5ce ( liv] canc] & cirrhosis ?r\gh 
ef=ts to increase adult hepatitis ,b    
vacc9ation & ma9ta9 *ildhood hepatitis  

,b vacc9ation1 p>ticul>ly )9 ! sett+ ( !
 opioid epidemic3 ,n[1 !re=e1 be x  ,t !
 ,h\se ( ,repres5tatives-- 7#a7 supports
 ! designation ( ,national ,adult       
,hepatitis ,b ,vacc9ation ,aw>5ess ,day2
  7#b7 recognizes ! importance ( provid+
 support = individuals to be te/$ =     
hepatitis ,b1 vacc9at+ ^? susceptible to
 hepatitis ,b1 & l9k+ to appropriate c>e
 ^? diagnos$ ) hepatitis ,b2 &  7#c7    
enc\rages a commitm5t to increas+ adult 
hepatitis ,b vacc9ation rates1 ma9ta9+  
*ildhood hepatitis ,b vacc9ation rates1 
& promot+ provid] & community aw>5ess ( 
adult hepatitis ,b vacc9ation 9 ord] to 
r$uce ! numb] ( new hepatitis ,b        
infections & hepatitis ,b-relat$ dea?s4